Could a common painkiller boost the Morning-After pill?
NCT ID NCT07449299
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two emergency contraception pills: levonorgestrel plus piroxicam (an anti-inflammatory drug) versus levonorgestrel alone. About 1,458 women aged 16-35 who had unprotected sex within 72 hours will participate. The goal is to see if adding piroxicam reduces pregnancy rates more effectively, especially in women weighing 75 kg or more.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRACEPTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and local mentors: a new way to empower teen girls on contraception?
- Could a single implant replace the morning-after pill?
- New condom materials put to the test: can plastic beat latex?
- New birth control pill aims to cut estrogen while boosting effectiveness
- Village women trained as mentors to help others take charge of birth control decisions
- Your DNA could determine if your birth control works